Antibiotics and antivirals do not modify experimentally-induced Creutzfeldt-Jakob disease in mice

J Neurol Neurosurg Psychiatry. 1981 Aug;44(8):723-4. doi: 10.1136/jnnp.44.8.723.

Abstract

Thiamphenicol, rifampicin, amantadine, cytosine arabinoside and isoprinosine were administered to mice which were inoculated with brain tissue containing Creutzfeldt-Jakob disease (CJD). All the mice developed disease within 3 to 6 months after inoculation. As there was no significant shift in incubation periods among animal groups of each drug administration and non-administration, these compounds had no effect in controlling experimental CJD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amantadine / therapeutic use
  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Creutzfeldt-Jakob Syndrome / drug therapy*
  • Cytarabine / therapeutic use
  • Humans
  • Inosine Pranobex / therapeutic use
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Rifampin / therapeutic use
  • Thiamphenicol / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents
  • Cytarabine
  • Amantadine
  • Thiamphenicol
  • Rifampin
  • Inosine Pranobex